Author:
Liu Zheng,Yin Rui,Ma Wenjuan,Li Zhijun,Guo Yijun,Wu Haixiao,Lin Yile,Chekhonin Vladimir P.,Peltzer Karl,Li Huiyang,Mao Min,Jian Xiqi,Zhang Chao
Funder
National Natural Science Foundation of China,China
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80(8 Suppl):1588–94.
2. Nagata M, Kudoh S, Mitsuoka S, Suzumura T, Umekawa K, Tanaka H, Matsuura K, Kimura T, Yoshimura N, Hirata K. Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations. Osaka City Med J. 2013;59(1):45–52.
3. Tsuya A, Kurata T, Tamura K, Fukuoka M. Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung cancer (Amsterdam Netherlands). 2007;57(2):229–32.
4. Zhang G, Liu Z, Chen Y, Zhang Y. High serum HDGF levels are predictive of bone metastasis and unfavorable prognosis in Non-small Cell Lung Cancer. Tohoku J Exp Med. 2017;242(2):101–8.
5. Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncology: Official J Am Soc Clin Oncol. 2010;28(29):4417–24.